Human Liver Microsomal Metabolism of (+)-Discodermolide
Authors:
- 23 September 2009
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Natural Products
- Vol. 72 (10) , 1748-1754
Abstract
The polyketide natural product (+)-discodermolide is a potent microtubule stabilizer that has generated considerable interest in its synthetic, medicinal, and biological chemistry. It progressed to early clinical oncology trials, where it showed some efficacy in terms of disease stabilization but also some indications of causing pneumotoxicity. Remarkably, there are no reports of its metabolism. Here, we examined its fate in mixed human liver microsomes. Due to limited availability of the agent, we chose a nanoflow liquid chromatography-electrospray ionization-mass spectrometry analytical approach employing quadrupolar ion trap and quadrupole−quadrupole-time-of-flight instruments for these studies. (+)-Discodermolide was rapidly converted to eight metabolites, with the left-side lactone (net oxidation) and the right-side diene (epoxidation followed by hydrolysis, along with an oxygen insertion product) being the most metabolically labile sites. Other sites of metabolism were the allylic and pendant methyl moieties in the C12−C14 region of the molecule. The results provide information on the metabolic soft spots of the molecule and can be used in further medicinal chemistry efforts to optimize discodermolide analogues.Keywords
This publication has 22 references indexed in Scilit:
- The Bound Conformation of Microtubule‐Stabilizing Agents: NMR Insights into the Bioactive 3D Structure of Discodermolide and DictyostatinChemistry – A European Journal, 2008
- Potentiation of Taxol Efficacy by Discodermolide in Ovarian Carcinoma Xenograft-Bearing MiceClinical Cancer Research, 2006
- Toward Understanding How the Lactone Moiety of Discodermolide Affects ActivityJournal of the American Chemical Society, 2005
- Large-Scale Synthesis of the Anti-Cancer Marine Natural Product (+)-Discodermolide. Part 5: Linkage of Fragments C1-6 and C7-24 and FinaleOrganic Process Research & Development, 2003
- Large-Scale Synthesis of the Anti-Cancer Marine Natural Product (+)-Discodermolide. Part 3: Synthesis of Fragment C15-21Organic Process Research & Development, 2003
- Large-Scale Synthesis of the Anti-Cancer Marine Natural Product (+)-Discodermolide. Part 2: Synthesis of Fragments C1-6 and C9-14Organic Process Research & Development, 2003
- Large-Scale Synthesis of the Anti-Cancer Marine Natural Product (+)-Discodermolide. Part 1: Synthetic Strategy and Preparation of a Common PrecursorOrganic Process Research & Development, 2003
- Large-Scale Synthesis of the Anti-Cancer Marine Natural Product (+)-Discodermolide. Part 4: Preparation of Fragment C7-24Organic Process Research & Development, 2003
- Semisynthetic Analogues of the Microtubule-Stabilizing Agent Discodermolide: Preparation and Biological ActivityJournal of Natural Products, 2002
- Immunosuppression by DiscodermolideAnnals of the New York Academy of Sciences, 1993